MiMedx.
biomedical company based in Marietta, Georgia, founded in 2008
- Reports this week
- 0
- Active events
- 0
- Connections
- 43
What's happening
Gone quiet
No new reports in 90+ days-
CMS proposed a sweeping overhaul of reimbursement policies on July 31, 2025.Some support2 reports2 developments inside
-
Trades are taking place on the Nasdaq stock exchange involving MiMedx.Some support3 reports
-
MiMedx has acquired Sanara MedTech for $350 million, combining their portfolios.Some support3 reports
-
Brokerage firms issued consensus recommendations regarding MiMedx on July 29, 2025.Some support1 report
-
MiMedx senior management participated in a conference hosted by Cantor on August 27, 2025.Some support1 report
-
Trump's pledge to unleash oil and gas is reported to benefit MiMedx stock.Some support1 report
-
MiMedx invested in Vaporox, a Denver-based company, and Vaporox's Vaporous Hyperoxia Therapy received 510(k) clearance from the FDA for its wound care offerings.Some support1 report
-
MiMedx reported that its free cash flow significantly exceeded statutory profit and its accrual ratio was negative as of August 7, 2025.Some support1 report
-
MiMedx Group is based in Marietta, Georgia, and CMS has proposed reimbursement reforms for skin substitutes.Well supported3 reports
-
MiMedx attended a symposium in Las Vegas on September 3, 2025. Paul Kim and Nicolas Mouawad were faculty members at the event.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around MiMedx this week
News at the entities that move MiMedx most-
Renaissance Technologies TransactionalRenaissance Technologies raised its stake in shares of Star Equity Holdings, Inc. on August 25, 2026.Moves MiMedx
-
Raymond James Financial TransactionalRaymond James Financial assumed coverage on Odyssey Therapeutics, and Manufacturers Life Insurance Company purchased a new position in its shares.Moves MiMedx
-
Securities and Exchange Commission StructuralGoosehead filed Form 8-K with the Securities and Exchange Commission on November 11, 2026.Moves MiMedx
-
Cantor Fitzgerald OperationalCantor Fitzgerald, Citigroup, and MarketBeat issued rating updates and price targets for Rigel Pharmaceuticals, Inc.Moves MiMedx
-
Georgia Shared contextJohnson was appointed by the Georgia Department of Transportation to oversee operations in Northwest Georgia.Moves MiMedx
-
Nasdaq StructuralMillerKnoll shares traded on Nasdaq and Benchmark upgraded its stock rating on October 31, 2026.Moves MiMedx
Connections
The 11 strongest of 43, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Renaissance Technologies Transactional
Renaissance Technologies increased its financial stake in MiMedx.
-
Nasdaq Structural
MiMedx operates as a publicly traded company on the Nasdaq stock exchange.
-
Raymond James Financial Transactional
RIF issued a target price for MiMedx, indicating a market assessment of potential value or future transaction.
-
Securities and Exchange Commission Structural
MiMedx operates under the oversight and regulatory framework of the Securities and Exchange Commission.
-
Cantor Fitzgerald Operational
Cantor Fitzgerald provides ongoing financial ratings and market analysis for MiMedx stock.
-
MediWound (Germany) Operational
MediWound and MiMedx are collaborating and supporting each other in clinical trials.
-
TipRanks Mentioned together
TipRanks provides financial analysis and consensus data regarding MiMedx.
-
Northland Mentioned together
Northland tracks MiMedx's market drivers, and MiMedx attends Northland's capital growth conferences.
Show all 11 connections
-
Georgia Shared context
MiMedx is located in the state of Georgia.
-
MarketAxess Mentioned together
Evidence is insufficient to establish a coupled relationship between MarketAxess and MiMedx.
-
New York Mentioned together
No evidence links New York to MiMedx; the company is based in Marietta, Georgia.
History
Events by the month they beganAugust 2026
1 eventJune 2026
8 events- CMS proposed a sweeping overhaul of reimbursement policies on July 31, 2025.
- Brokerage firms issued consensus recommendations regarding MiMedx on July 29, 2025.
- MiMedx senior management participated in a conference hosted by Cantor on August 27, 2025.
- Trump's pledge to unleash oil and gas is reported to benefit MiMedx stock.
- MiMedx invested in Vaporox, a Denver-based company, and Vaporox's Vaporous Hyperoxia Therapy received 510(k) clearance from the FDA for its wound care offerings.
- MiMedx reported that its free cash flow significantly exceeded statutory profit and its accrual ratio was negative as of August 7, 2025.
- MiMedx Group is based in Marietta, Georgia, and CMS has proposed reimbursement reforms for skin substitutes.
- MiMedx attended a symposium in Las Vegas on September 3, 2025. Paul Kim and Nicolas Mouawad were faculty members at the event.